Vertex Pharmaceuticals Incorporated (VX1)
Market Closed
19 Jun, 20:00
€
391. 30
-2.35
-0.597%
€
- Market Cap
30.83 P/E Ratio
- Div Yield
155 Volume
14.94 Eps
€ 393.65
Previous Close Want to track VX1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 4.4 | - |
| | | 5.14 | - |
| | | 4.58 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
VX1 Earnings Reports FAQ
What is the earnings per share (EPS) for VX1?
The current EPS is 14.94.
What is the company's earnings growth rate?
Vertex Pharmaceuticals Incorporated has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Vertex Pharmaceuticals Incorporated has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Vertex Pharmaceuticals Incorporated are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for VX1 at this time, as Vertex Pharmaceuticals Incorporated has no recent EPS data to calculate it.
